INTERNATIONAL PATENT: JANSSEN BIOTECH, INC. FILES APPLICATION FOR "USE OF AMIVANTAMAB TO TREAT HEAD AND NECK CANCER"

GENEVA, Aug. 4 -- JANSSEN BIOTECH, INC. (800/850 Ridgeview DriveHorsham, Pennsylvania 19044) filed a patent application (PCT/IB2025/050613) for "USE OF AMIVANTAMAB TO TREAT HEAD AND NECK CANCER" on Jan 21, 2025. With publication no. WO/2025/158277, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BAUML, Joshua (1400 McKean RoadSpring House, Pennsylvania 19477), KNOBLAUCH, Roland (1400 McKean RoadSpring House, Pennsylvania 19477), BAIG, Mahadi (US Highway 22 WBridgewater, New Jersey 08807)

Abstract: The present invention...